Publications by authors named "Brenda Jesernig"

Claim this Profile
N
Neoantigen-specific CD4 T cells in human melanoma have diverse differentiation states and correlate with CD8 T cell, macrophage, and B cell function.
Joshua R Veatch, Sylvia M Lee, Carolyn Shasha, Naina Singhi, Julia L Szeto, Brenda Jesernig

Cancer Cell· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells.
Joshua R Veatch, Naina Singhi, Shivani Srivastava, Julia L Szeto, Brenda Jesernig

J Clin Invest· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab.
Joshua R Veatch, Naina Singhi, Brenda Jesernig, Kelly G Paulson, Jonathan Zalevsky

J Immunother Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous CD4 T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic and () Driver Mutations.
Joshua R Veatch, Brenda L Jesernig, Julia Kargl, Matthew Fitzgibbon, Sylvia M Lee

Cancer Immunol Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.
Joshua R Veatch, Sylvia M Lee, Matthew Fitzgibbon, I-Ting Chow, Brenda Jesernig

J Clin Invest· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis